The ABC Trial: protocol for the “Wake Up and Breathe” sedation and weaning strategy (Lancet, 2008) please click on this link.
Increased scrutiny has recently been placed on appropriate titration of sedative and analgesic medications in critically ill patients, especially those being treated with mechanical ventilation. Patient comfort should be a primary goal in the intensive care unit (ICU), including adequate pain control, anxiolysis, and prevention and treatment of delirium. However, achieving the appropriate balance of sedation and analgesia is challenging. Without rational and agreed upon target levels of sedation, it is likely that different members of the healthcare team will have disparate treatment goals, increasing the chance for iatrogenic complications and potentially impeding recovery.
The clinical practice guidelines of the Society of Critical Care Medicine emphasize the need for goal-directed delivery of psychoactive medications to avoid oversedation and to promote earlier extubation (Jacobi, J et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med; 30:119-141, 2002.) Most available evidence regarding sedatives and analgesics in ICU patients indicates that it may be less important which drugs are delivered than their proper titration using goal-directed delivery to optimize patient comfort while avoiding complications such as prolonged mechanical ventilation or reintubation. Goal-directed delivery of sedatives is best accomplished by the use of sedation scales to help the medical team agree on a target sedation level for each individual patient. Few available sedation scales have been appropriately tested for reliability and validity. Sedation scales with broad acceptance include (among others) the Ramsay scale, the Sedation Agitation Scale (SAS), the Motor Activity Assessment Scale (MAAS), the COMFORT scale for pediatric patients, and the Richmond Agitation-Sedation Scale (RASS). These are all discussed to some degree in the references for the sedation clinical practice guidelines and the RASS. The Richmond Agitation-Sedation Scale (RASS) was developed by a multidisciplinary team at Virginia Commonwealth University in Richmond, Virginia. A unique feature of RASS is that it uses the duration of eye contact following verbal stimulation as the principal means of titrating sedation.